Revenue, last quarter
$19M
−8.4% vs same quarter last year
Net income
−$9.3M
−8.1% vs same quarter last year
EPS, diluted
−$0.16
+15.8% vs same quarter last year
Operating cash flow
−$8.7M
−52% vs same quarter last year
Source: SEC XBRL filings · latest filing
- Revenue
- Net income
Show the numbers
| Year | Revenue | Net income |
|---|---|---|
| FY25 | $80.3M | −$38.8M |
| FY24 | $69.3M | −$37.8M |
| FY23 | $58.5M | −$46.7M |
| FY22 | $41.4M | −$44.3M |
| FY21 | $29.5M | −$33.3M |
| FY20 | $18.2M | −$28.8M |
| FY19 | $15.4M | −$22.4M |
| FY18 | $8.3M | −$21.1M |
| FY17 | $4.2M | −$21.3M |
| FY16 | - | - |
- Gross margin
- Operating margin
- Net margin
Show the numbers
| Year | Gross margin | Operating margin | Net margin |
|---|---|---|---|
| FY25 | 67.7% | −42% | −48.3% |
| FY24 | 67.1% | −49.2% | −54.5% |
| FY23 | 68.6% | −75.4% | −79.9% |
| FY22 | 65.3% | −94.2% | −106.9% |
| FY21 | 63.9% | −100% | −112.9% |
| FY20 | 61.7% | −138.8% | −158.1% |
| FY19 | 60% | −124.1% | −145.2% |
| FY18 | 35.6% | −214.9% | −254.9% |
| FY17 | 59.6% | −398.7% | −502.6% |
| FY16 | - | - | - |
Show the numbers
| Year | Free cash flow |
|---|---|
| FY25 | −$28.7M |
| FY24 | −$42.6M |
| FY23 | −$41.5M |
| FY22 | −$41.6M |
| FY21 | −$31.1M |
| FY20 | −$24.6M |
| FY19 | −$25.7M |
| FY18 | −$20M |
| FY17 | −$16.5M |
| FY16 | - |
- TELA Bio
- Healthcare median
Show the numbers
| Year | TELA Bio | Healthcare median |
|---|---|---|
| FY25 | −48.3% | −30.6% |
| FY24 | −54.5% | −47% |
| FY23 | −79.9% | −58% |
| FY22 | −106.9% | −80.4% |
| FY21 | −112.9% | −71.8% |
| FY20 | −158.1% | −62.2% |
| FY19 | −145.2% | −46.2% |
| FY18 | −254.9% | −49.6% |
| FY17 | −502.6% | −45.9% |
| FY16 | - | −36% |